Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.100
-0.580 (-12.39%)
At close: Sep 26, 2025, 4:00 PM EDT
4.150
+0.050 (1.22%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Organogenesis Holdings Employees
Organogenesis Holdings had 869 employees as of December 31, 2024. The number of employees increased by 7 or 0.81% compared to the previous year.
Employees
869
Change (1Y)
7
Growth (1Y)
0.81%
Revenue / Employee
$494,282
Profits / Employee
-$17,937
Market Cap
520.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ORGO News
- 1 day ago - Why Is Organogenesis Stock Trading Lower Friday? - Benzinga
- 2 days ago - Organogenesis Provides Update on Second Phase 3 ReNu® Study - GlobeNewsWire
- 4 weeks ago - Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 7 weeks ago - Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation - GlobeNewsWire
- 3 months ago - Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha